The growth patterns of a child changes from uterine life until the end of puberty. Height velocity is highest in utero and declines after birth until puberty when it rises again. Important hormonal regulators of childhood growth are growth hormone, insulin-like growth factor 1, sex steroids, and thyroid hormone. This review gives an overview of these hormonal regulators of growth and their interplay with nutrition and other key players such as inflammatory cytokines.

1.
Delemarre-van de Waal HA: Environment al factors influencing growth and pubertal development. Environ Health Perspect 1993;101(suppl 2)39–44.
2.
Tanner JM, Davies PS: Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985;107: 317–329.
3.
Karlberg J: A biologically-oriented mathematical model (ICP) for human growth. Acta Paediatr Scand Suppl 1989;350: 70–94.
4.
Botton J, et al: Parental body size and early weight and height growth velocities in their offspring. Early Hum Dev 2010;86: 445–450.
5.
Kappy MS, Allen DB, Geffner ME: Principles and Practice of Pediatric Endocrinology. Springfield, Charles C. Thomas, 2005, p 741.
6.
Davies JH, Cheetham T: Investigation and management of tall stature. Arch Dis Child 2014;99: 772–777.
7.
Martin L, Collin J: An introduction to growth and atypical growth in childhood and adolescence. Nurs Child Young People 2015;27: 29–37; quiz 38.
8.
Granados A, Gebremariam A, Lee JM: Relationship between timing of peak height velocity and pubertal staging in boys and girls. J Clin Res Pediatr Endocrinol 2015;7: 235–237.
9.
Abbassi V: Growth and normal puberty. Pediatrics 1998;102: 507–511.
10.
Mackie EJ, Ahmed YA, Tatarczuch L, Chen K-S, Mirams M: Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 2008;40: 46–62.
11.
Kronenberg HM: Developmental regulation of the growth plate. Nature 2003;423: 332–336.
12.
Wang X, et al: FGFR3/fibroblast growth factor receptor 3 inhibits autophagy through decreasing the ATG12-ATG5 conjugate, leading to the delay of cartilage development in achondroplasia. Autophagy 2015;11: 1998–2013.
13.
Camacho-Hübner C: Normal physiology of growth hormone and insulin-like growth factors in childhood; in De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Gross man A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO (eds): Endotext. South Dartmouth, MDText.com, Inc., 2000.
14.
Meinhardt UJ, Ho KKY: Modulation of growth hormone action by sex steroids. Clin Endocrinol (Oxf) 2006;65: 413–422.
15.
Shim KS: Pubertal growth and epiphyseal fusion. Ann Pediatr Endocrinol Metab 2015;20: 8–12.
16.
Baxter RC: Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 1988;67: 265–272.
17.
Wit JM, Camacho-Hübner C: Endocrine regulation of longitudinal bone growth. Endocr Dev 2011;21: 30–41.
18.
Wu S, Yang W, De Luca F: Insulin-like growth factor-independent effects of growth hormone on growth plate chondrogenesis and longitudinal bone growth. Endocrinology 2015;156: 2541–2551.
19.
Yakar S, Isaksson O: Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: lessons from mouse models. Growth Horm IGF Res 2015;28: 26–42.
20.
Begemann M, et al: Paternally inherited IGF2 mutation and growth restriction. N Engl J Med 2015;373: 349–356.
21.
Backeljauw PF, Chernausek SD: The insulin-like growth factors and growth disorders of childhood. Endocrinol Metab Clin North Am 2012;41: 265–282.
22.
Zhang F, He Q, Tsang WP, Garvey WT, Chan WY, Wan C: Insulin exerts direct, IGF-1 independent actions in growth plate chondrocytes. Bone Res 2014;2: 14012.
23.
Giovannucci E, et al: Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 2003;12: 84–89.
24.
Robson H, Siebler T, Stevens DA, Shalet SM, Williams GR: Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. Endocrinology 2000;141: 3887–3897.
25.
Williams GR: Thyroid hormone actions in cartilage and bone. Eur Thyroid J 2013;2: 3–13.
26.
Chagin AS, Chrysis D, Takigawa M, Ritzen EM, Sävendahl L: Locally produced estrogen promotes fetal rat metatarsal bone growth; an effect mediated through increased chondrocyte proliferation and decreased apoptosis. J Endocrinol 2006;188: 193–203.
27.
Hess RA: Estrogen in the adult male reproductive tract: a review. Reprod Biol Endocrinol 2003;1: 52.
28.
Oz OK, Millsaps R, Welch R, Birch J, Zerwekh JE: Expression of aromatase in the human growth plate. J Mol Endocrinol 2001;27: 249–253.
29.
Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, Ziegler RG: Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal Chem 2007;79: 7813–7821.
30.
Rogol AD: Gender and hormonal regula tion of growth. J Pediatr Endocrinol Metab 2004;17(suppl 4):1259–1265.
31.
Rose SR, et al: Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J Clin Endocrinol Metab 1991;73: 428–435.
32.
Cole TJ, Ahmed ML, Preece MA, Hindmarsh P, Dunger DB: The relationship between insulin-like growth factor 1, sex steroids and timing of the pubertal growth spurt. Clin Endocrinol (Oxf) 2015;82: 862–869.
33.
Delemarre-van de Waal HA, van Coeverden SC, Rotteveel J: Hormonal determinants of pubertal growth. J Pediatr Endocrinol Metab 2001;14(suppl 6):1521–1526.
34.
Chagin AS, Vannesjö J, Sävendahl L: Androgen receptor modulation does not affect longitudinal growth of cultured fetal rat metatarsal bones. Horm Res 2009;71: 219–227.
35.
Börjesson AE, et al: The role of estrogen receptor-α and its activation function-1 for growth plate closure in female mice. Am J Physiol Endocrinol Metab 2012;302:E1381–1389.
36.
Thomas P, Pang Y, Filardo EJ, Dong J: Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005;146: 624–632.
37.
Chagin AS, Sävendahl L: GPR30 estrogen receptor expression in the growth plate declines as puberty progresses. J Clin Endocrinol Metab 2007;92: 4873–4877.
38.
Nilsson O, et al: Localization of estrogen receptors-alpha and -beta and androgen receptor in the human growth plate at different pubertal stages. J Endocrinol 2003;177: 319–326.
39.
Simm PJ, Russo VC, Werther GA: The effect of selective oestrogen receptor antagonists in an in vitro model of growth plate chondrogenesis. Endocrine 2011;40: 27–34.
40.
Rochira V, Kara E, Carani C: The endocrine role of estrogens on human male skeleton. Int J Endocrinol 2015;2015: 165215.
41.
Chagin AS, et al: Estrogen receptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice. J Bone Miner Res 2004;19: 72–77.
42.
Parikka V, et al: Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice. Eur J Endocrinol 2005;152: 301–314.
43.
Sims NA, et al: Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone 2002;30: 18–25.
44.
Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C: Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(–/–) mice. J Clin Invest 1999;104: 895–901.
45.
Smith EP, Specker B, Korach KS: Recent experimental and clinical findings in the skeleton associated with loss of estrogen hormone or estrogen receptor activity. J Steroid Biochem Mol Biol 2010;118: 264–272.
46.
Quaynor SD, et al: Delayed puberty and estrogen resistance in a woman with estrogen receptor α variant. N Engl J Med 2013;369: 164–171.
47.
Smith EP, et al: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331: 1056–1061.
48.
Odle AK, Haney A, Allensworth-James M, Akhter N, Childs GV: Adipocyte versus pituitary leptin in the regulation of pituitary hormones: somatotropes develop normally in the absence of circulating leptin. Endocrinology 2014;155: 4316–4328.
49.
Tannenbaum GS, Gurd W, Lapointe M: Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology 1998;139: 3871–3875.
50.
Maor G, Rochwerger M, Segev Y, Phillip M: Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res 2002;17: 1034–1043.
51.
Nakajima R, Inada H, Koike T, Yamano T: Effects of leptin to cultured growth plate chondrocytes. Horm Res 2003;60: 91–98.
52.
Simon D, Fernando C, Czernichow P, Prieur A-M: Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. J Rheumatol 2002;29: 1296–1300.
53.
Mårtensson K, Chrysis D, Sävendahl L: Interleukin-1beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J Bone Miner Res 2004;19: 1805–1812.
54.
Kritsch KR, Murali S, Adamo ML, Ney DM: Dexamethasone decreases serum and liver IGF-I and maintains liver IGF-I mRNA in parenterally fed rats. Am J Physiol Regul Integr Comp Physiol 2002;282:R528–R536.
55.
Mushtaq T, Ahmed SF: The impact of corticosteroids on growth and bone health. Arch Dis Child 2002;87: 93–96.
56.
Chrysis D, Nilsson O, Ritzen EM, Sävendahl L: Apoptosis is developmentally regulated in rat growth plate. Endocrine 2002;18: 271–278.
57.
De Boeck K, De Baets F, Malfroot A, Desager K, Mouchet F, Proesmans M: Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients? Eur J Pediatr 2007;166: 23–28.
58.
Ribeiro D, Zawadynski S, Pittet LF, Chevalley T, Girardin E, Parvex P: Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome. Eur J Pediatr 2015;174: 911–917.
59.
Chrysis D, Ritzen EM, Sävendahl L: Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes. J Endocrinol 2003;176: 331–337.
60.
Locker M, Kellermann O, Boucquey M, Khun H, Huerre M, Poliard A: Paracrine and autocrine signals promoting full chondrogenic differentiation of a mesoblastic cell line. J Bone Miner Res 2004;19: 100–110.
61.
Bechtold S, Roth J: Natural history of growth and body composition in juvenile idiopathic arthritis. Horm Res 2009;72(suppl 1):13–19.
62.
Hong CY, et al: Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol Cell Biol 2004;24: 2593–2604.
63.
MacRae VE, Farquharson C, Ahmed SF: The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. J Endocrinol 2006;189: 319–328.
64.
Prentice A, Schoenmakers I, Laskey MA, de Bono S, Ginty F, Goldberg GR: Nutrition and bone growth and development. Proc Nutr Soc 2006;65: 348–360.
65.
Freemark M: Metabolomics in nutrition research: biomarkers predicting mortality in children with severe acute malnutrition. Food Nutr Bull 2015;36: 88–92.
66.
Gat-Yablonski G, Shtaif B, Abraham E, Phillip M: Nutrition-induced catch-up growth at the growth plate. J Pediatr Endocrinol Metab 2008;21: 879–893.
67.
Wu S, Levenson A, Kharitonenkov A, De Luca F: Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate. J Biol Chem 2012;287: 26060–26067.
68.
van Stuijvenberg ME, Nel J, Schoeman SE, Lombard CJ, du Plessis LM, Dhansay MA: Low intake of calcium and vitamin D, but not zinc, iron or vitamin A, is associated with stunting in 2- to 5-year-old children. Nutrition 2015;31: 841–846.
69.
Munns CF, et al: Global consensus recommendations on prevention and management of nutritional rickets. Horm Res Paediatr 2016;85: 83–106.
70.
Adriani M, Wirjatmadi B: The effect of adding zinc to vitamin A on IGF-1, bone age and linear growth in stunted children. J Trace Elem Med Biol 2014; 28: 431–435.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.